ARCHIVES

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

In Brief: Hayard Of Sloan-Kettering, Leder Of Harvard to Share 1985 Bristol-Myer Award Of $50,000

March 29, 1985

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

In Brief: Mihich, Kennedy, Aust New Presidents; Loeb, Coltman, Cady Presidents Elect; Carbone Honored

May 29, 1987

NCI CTEP Approved Trials For the Month of September

September 27, 2013

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982